Global Hepatitis C Virus (HCV) Market Research Report 2023

Report ID: 1994700 | Published Date: Jan 2025 | No. of Page: 110 | Base Year: 2024 | Rating: 4.6 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Hepatitis C Virus (HCV) Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
        1.2.2 Hepatitis C Drugs
        1.2.3 Hepatitis C Test Kit
    1.3 Market by Application
        1.3.1 Global Hepatitis C Virus (HCV) Market Growth by Application: 2018 VS 2022 VS 2029
        1.3.2 Hospitals
        1.3.3 Ambulatory Surgical Centers
        1.3.4 Diagnostic Centers
    1.4 Study Objectives
    1.5 Years Considered
    1.6 Years Considered
2 Global Growth Trends
    2.1 Global Hepatitis C Virus (HCV) Market Perspective (2018-2029)
    2.2 Hepatitis C Virus (HCV) Growth Trends by Region
        2.2.1 Global Hepatitis C Virus (HCV) Market Size by Region: 2018 VS 2022 VS 2029
        2.2.2 Hepatitis C Virus (HCV) Historic Market Size by Region (2018-2023)
        2.2.3 Hepatitis C Virus (HCV) Forecasted Market Size by Region (2024-2029)
    2.3 Hepatitis C Virus (HCV) Market Dynamics
        2.3.1 Hepatitis C Virus (HCV) Industry Trends
        2.3.2 Hepatitis C Virus (HCV) Market Drivers
        2.3.3 Hepatitis C Virus (HCV) Market Challenges
        2.3.4 Hepatitis C Virus (HCV) Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Hepatitis C Virus (HCV) Players by Revenue
        3.1.1 Global Top Hepatitis C Virus (HCV) Players by Revenue (2018-2023)
        3.1.2 Global Hepatitis C Virus (HCV) Revenue Market Share by Players (2018-2023)
    3.2 Global Hepatitis C Virus (HCV) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Hepatitis C Virus (HCV) Revenue
    3.4 Global Hepatitis C Virus (HCV) Market Concentration Ratio
        3.4.1 Global Hepatitis C Virus (HCV) Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Hepatitis C Virus (HCV) Revenue in 2022
    3.5 Hepatitis C Virus (HCV) Key Players Head office and Area Served
    3.6 Key Players Hepatitis C Virus (HCV) Product Solution and Service
    3.7 Date of Enter into Hepatitis C Virus (HCV) Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Hepatitis C Virus (HCV) Breakdown Data by Type
    4.1 Global Hepatitis C Virus (HCV) Historic Market Size by Type (2018-2023)
    4.2 Global Hepatitis C Virus (HCV) Forecasted Market Size by Type (2024-2029)
5 Hepatitis C Virus (HCV) Breakdown Data by Application
    5.1 Global Hepatitis C Virus (HCV) Historic Market Size by Application (2018-2023)
    5.2 Global Hepatitis C Virus (HCV) Forecasted Market Size by Application (2024-2029)
6 North America
    6.1 North America Hepatitis C Virus (HCV) Market Size (2018-2029)
    6.2 North America Hepatitis C Virus (HCV) Market Growth Rate by Country: 2018 VS 2022 VS 2029
    6.3 North America Hepatitis C Virus (HCV) Market Size by Country (2018-2023)
    6.4 North America Hepatitis C Virus (HCV) Market Size by Country (2024-2029)
    6.5 United States
    6.6 Canada
7 Europe
    7.1 Europe Hepatitis C Virus (HCV) Market Size (2018-2029)
    7.2 Europe Hepatitis C Virus (HCV) Market Growth Rate by Country: 2018 VS 2022 VS 2029
    7.3 Europe Hepatitis C Virus (HCV) Market Size by Country (2018-2023)
    7.4 Europe Hepatitis C Virus (HCV) Market Size by Country (2024-2029)
    7.5 Germany
    7.6 France
    7.7 U.K.
    7.8 Italy
    7.9 Russia
    7.10 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Hepatitis C Virus (HCV) Market Size (2018-2029)
    8.2 Asia-Pacific Hepatitis C Virus (HCV) Market Growth Rate by Region: 2018 VS 2022 VS 2029
    8.3 Asia-Pacific Hepatitis C Virus (HCV) Market Size by Region (2018-2023)
    8.4 Asia-Pacific Hepatitis C Virus (HCV) Market Size by Region (2024-2029)
    8.5 China
    8.6 Japan
    8.7 South Korea
    8.8 Southeast Asia
    8.9 India
    8.10 Australia
9 Latin America
    9.1 Latin America Hepatitis C Virus (HCV) Market Size (2018-2029)
    9.2 Latin America Hepatitis C Virus (HCV) Market Growth Rate by Country: 2018 VS 2022 VS 2029
    9.3 Latin America Hepatitis C Virus (HCV) Market Size by Country (2018-2023)
    9.4 Latin America Hepatitis C Virus (HCV) Market Size by Country (2024-2029)
    9.5 Mexico
    9.6 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Hepatitis C Virus (HCV) Market Size (2018-2029)
    10.2 Middle East & Africa Hepatitis C Virus (HCV) Market Growth Rate by Country: 2018 VS 2022 VS 2029
    10.3 Middle East & Africa Hepatitis C Virus (HCV) Market Size by Country (2018-2023)
    10.4 Middle East & Africa Hepatitis C Virus (HCV) Market Size by Country (2024-2029)
    10.5 Turkey
    10.6 Saudi Arabia
    10.7 UAE
11 Key Players Profiles
    11.1 Gilead
        11.1.1 Gilead Company Detail
        11.1.2 Gilead Business Overview
        11.1.3 Gilead Hepatitis C Virus (HCV) Introduction
        11.1.4 Gilead Revenue in Hepatitis C Virus (HCV) Business (2018-2023)
        11.1.5 Gilead Recent Development
    11.2 Merck
        11.2.1 Merck Company Detail
        11.2.2 Merck Business Overview
        11.2.3 Merck Hepatitis C Virus (HCV) Introduction
        11.2.4 Merck Revenue in Hepatitis C Virus (HCV) Business (2018-2023)
        11.2.5 Merck Recent Development
    11.3 AbbVie
        11.3.1 AbbVie Company Detail
        11.3.2 AbbVie Business Overview
        11.3.3 AbbVie Hepatitis C Virus (HCV) Introduction
        11.3.4 AbbVie Revenue in Hepatitis C Virus (HCV) Business (2018-2023)
        11.3.5 AbbVie Recent Development
    11.4 J&J
        11.4.1 J&J Company Detail
        11.4.2 J&J Business Overview
        11.4.3 J&J Hepatitis C Virus (HCV) Introduction
        11.4.4 J&J Revenue in Hepatitis C Virus (HCV) Business (2018-2023)
        11.4.5 J&J Recent Development
    11.5 Bristol-Myers Squibb
        11.5.1 Bristol-Myers Squibb Company Detail
        11.5.2 Bristol-Myers Squibb Business Overview
        11.5.3 Bristol-Myers Squibb Hepatitis C Virus (HCV) Introduction
        11.5.4 Bristol-Myers Squibb Revenue in Hepatitis C Virus (HCV) Business (2018-2023)
        11.5.5 Bristol-Myers Squibb Recent Development
    11.6 Kawin
        11.6.1 Kawin Company Detail
        11.6.2 Kawin Business Overview
        11.6.3 Kawin Hepatitis C Virus (HCV) Introduction
        11.6.4 Kawin Revenue in Hepatitis C Virus (HCV) Business (2018-2023)
        11.6.5 Kawin Recent Development
    11.7 Abbott
        11.7.1 Abbott Company Detail
        11.7.2 Abbott Business Overview
        11.7.3 Abbott Hepatitis C Virus (HCV) Introduction
        11.7.4 Abbott Revenue in Hepatitis C Virus (HCV) Business (2018-2023)
        11.7.5 Abbott Recent Development
    11.8 Siemens Healthineers
        11.8.1 Siemens Healthineers Company Detail
        11.8.2 Siemens Healthineers Business Overview
        11.8.3 Siemens Healthineers Hepatitis C Virus (HCV) Introduction
        11.8.4 Siemens Healthineers Revenue in Hepatitis C Virus (HCV) Business (2018-2023)
        11.8.5 Siemens Healthineers Recent Development
    11.9 Roche Diagnostics
        11.9.1 Roche Diagnostics Company Detail
        11.9.2 Roche Diagnostics Business Overview
        11.9.3 Roche Diagnostics Hepatitis C Virus (HCV) Introduction
        11.9.4 Roche Diagnostics Revenue in Hepatitis C Virus (HCV) Business (2018-2023)
        11.9.5 Roche Diagnostics Recent Development
    11.10 altona Diagnostics
        11.10.1 altona Diagnostics Company Detail
        11.10.2 altona Diagnostics Business Overview
        11.10.3 altona Diagnostics Hepatitis C Virus (HCV) Introduction
        11.10.4 altona Diagnostics Revenue in Hepatitis C Virus (HCV) Business (2018-2023)
        11.10.5 altona Diagnostics Recent Development
    11.11 GeneProof
        11.11.1 GeneProof Company Detail
        11.11.2 GeneProof Business Overview
        11.11.3 GeneProof Hepatitis C Virus (HCV) Introduction
        11.11.4 GeneProof Revenue in Hepatitis C Virus (HCV) Business (2018-2023)
        11.11.5 GeneProof Recent Development
    11.12 Sansure Biotech
        11.12.1 Sansure Biotech Company Detail
        11.12.2 Sansure Biotech Business Overview
        11.12.3 Sansure Biotech Hepatitis C Virus (HCV) Introduction
        11.12.4 Sansure Biotech Revenue in Hepatitis C Virus (HCV) Business (2018-2023)
        11.12.5 Sansure Biotech Recent Development
    11.13 Daan Gene
        11.13.1 Daan Gene Company Detail
        11.13.2 Daan Gene Business Overview
        11.13.3 Daan Gene Hepatitis C Virus (HCV) Introduction
        11.13.4 Daan Gene Revenue in Hepatitis C Virus (HCV) Business (2018-2023)
        11.13.5 Daan Gene Recent Development
    11.14 BGI Group
        11.14.1 BGI Group Company Detail
        11.14.2 BGI Group Business Overview
        11.14.3 BGI Group Hepatitis C Virus (HCV) Introduction
        11.14.4 BGI Group Revenue in Hepatitis C Virus (HCV) Business (2018-2023)
        11.14.5 BGI Group Recent Development
    11.15 Abiores
        11.15.1 Abiores Company Detail
        11.15.2 Abiores Business Overview
        11.15.3 Abiores Hepatitis C Virus (HCV) Introduction
        11.15.4 Abiores Revenue in Hepatitis C Virus (HCV) Business (2018-2023)
        11.15.5 Abiores Recent Development
    11.16 ACON Biotech
        11.16.1 ACON Biotech Company Detail
        11.16.2 ACON Biotech Business Overview
        11.16.3 ACON Biotech Hepatitis C Virus (HCV) Introduction
        11.16.4 ACON Biotech Revenue in Hepatitis C Virus (HCV) Business (2018-2023)
        11.16.5 ACON Biotech Recent Development
    11.17 Nectar Lifesciences
        11.17.1 Nectar Lifesciences Company Detail
        11.17.2 Nectar Lifesciences Business Overview
        11.17.3 Nectar Lifesciences Hepatitis C Virus (HCV) Introduction
        11.17.4 Nectar Lifesciences Revenue in Hepatitis C Virus (HCV) Business (2018-2023)
        11.17.5 Nectar Lifesciences Recent Development
    11.18 Everlywell
        11.18.1 Everlywell Company Detail
        11.18.2 Everlywell Business Overview
        11.18.3 Everlywell Hepatitis C Virus (HCV) Introduction
        11.18.4 Everlywell Revenue in Hepatitis C Virus (HCV) Business (2018-2023)
        11.18.5 Everlywell Recent Development
    11.19 bioLytical
        11.19.1 bioLytical Company Detail
        11.19.2 bioLytical Business Overview
        11.19.3 bioLytical Hepatitis C Virus (HCV) Introduction
        11.19.4 bioLytical Revenue in Hepatitis C Virus (HCV) Business (2018-2023)
        11.19.5 bioLytical Recent Development
    11.20 Liferiver
        11.20.1 Liferiver Company Detail
        11.20.2 Liferiver Business Overview
        11.20.3 Liferiver Hepatitis C Virus (HCV) Introduction
        11.20.4 Liferiver Revenue in Hepatitis C Virus (HCV) Business (2018-2023)
        11.20.5 Liferiver Recent Development
    11.21 3B BlackBio Biotech India Limited
        11.21.1 3B BlackBio Biotech India Limited Company Detail
        11.21.2 3B BlackBio Biotech India Limited Business Overview
        11.21.3 3B BlackBio Biotech India Limited Hepatitis C Virus (HCV) Introduction
        11.21.4 3B BlackBio Biotech India Limited Revenue in Hepatitis C Virus (HCV) Business (2018-2023)
        11.21.5 3B BlackBio Biotech India Limited Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Hepatitis C Virus (HCV) Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
    Table 2. Key Players of Hepatitis C Drugs
    Table 3. Key Players of Hepatitis C Test Kit
    Table 4. Global Hepatitis C Virus (HCV) Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
    Table 5. Global Hepatitis C Virus (HCV) Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 6. Global Hepatitis C Virus (HCV) Market Size by Region (2018-2023) & (US$ Million)
    Table 7. Global Hepatitis C Virus (HCV) Market Share by Region (2018-2023)
    Table 8. Global Hepatitis C Virus (HCV) Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 9. Global Hepatitis C Virus (HCV) Market Share by Region (2024-2029)
    Table 10. Hepatitis C Virus (HCV) Market Trends
    Table 11. Hepatitis C Virus (HCV) Market Drivers
    Table 12. Hepatitis C Virus (HCV) Market Challenges
    Table 13. Hepatitis C Virus (HCV) Market Restraints
    Table 14. Global Hepatitis C Virus (HCV) Revenue by Players (2018-2023) & (US$ Million)
    Table 15. Global Hepatitis C Virus (HCV) Market Share by Players (2018-2023)
    Table 16. Global Top Hepatitis C Virus (HCV) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis C Virus (HCV) as of 2022)
    Table 17. Ranking of Global Top Hepatitis C Virus (HCV) Companies by Revenue (US$ Million) in 2022
    Table 18. Global 5 Largest Players Market Share by Hepatitis C Virus (HCV) Revenue (CR5 and HHI) & (2018-2023)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Hepatitis C Virus (HCV) Product Solution and Service
    Table 21. Date of Enter into Hepatitis C Virus (HCV) Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Hepatitis C Virus (HCV) Market Size by Type (2018-2023) & (US$ Million)
    Table 24. Global Hepatitis C Virus (HCV) Revenue Market Share by Type (2018-2023)
    Table 25. Global Hepatitis C Virus (HCV) Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 26. Global Hepatitis C Virus (HCV) Revenue Market Share by Type (2024-2029)
    Table 27. Global Hepatitis C Virus (HCV) Market Size by Application (2018-2023) & (US$ Million)
    Table 28. Global Hepatitis C Virus (HCV) Revenue Market Share by Application (2018-2023)
    Table 29. Global Hepatitis C Virus (HCV) Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 30. Global Hepatitis C Virus (HCV) Revenue Market Share by Application (2024-2029)
    Table 31. North America Hepatitis C Virus (HCV) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 32. North America Hepatitis C Virus (HCV) Market Size by Country (2018-2023) & (US$ Million)
    Table 33. North America Hepatitis C Virus (HCV) Market Size by Country (2024-2029) & (US$ Million)
    Table 34. Europe Hepatitis C Virus (HCV) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 35. Europe Hepatitis C Virus (HCV) Market Size by Country (2018-2023) & (US$ Million)
    Table 36. Europe Hepatitis C Virus (HCV) Market Size by Country (2024-2029) & (US$ Million)
    Table 37. Asia-Pacific Hepatitis C Virus (HCV) Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 38. Asia-Pacific Hepatitis C Virus (HCV) Market Size by Region (2018-2023) & (US$ Million)
    Table 39. Asia-Pacific Hepatitis C Virus (HCV) Market Size by Region (2024-2029) & (US$ Million)
    Table 40. Latin America Hepatitis C Virus (HCV) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 41. Latin America Hepatitis C Virus (HCV) Market Size by Country (2018-2023) & (US$ Million)
    Table 42. Latin America Hepatitis C Virus (HCV) Market Size by Country (2024-2029) & (US$ Million)
    Table 43. Middle East & Africa Hepatitis C Virus (HCV) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 44. Middle East & Africa Hepatitis C Virus (HCV) Market Size by Country (2018-2023) & (US$ Million)
    Table 45. Middle East & Africa Hepatitis C Virus (HCV) Market Size by Country (2024-2029) & (US$ Million)
    Table 46. Gilead Company Detail
    Table 47. Gilead Business Overview
    Table 48. Gilead Hepatitis C Virus (HCV) Product
    Table 49. Gilead Revenue in Hepatitis C Virus (HCV) Business (2018-2023) & (US$ Million)
    Table 50. Gilead Recent Development
    Table 51. Merck Company Detail
    Table 52. Merck Business Overview
    Table 53. Merck Hepatitis C Virus (HCV) Product
    Table 54. Merck Revenue in Hepatitis C Virus (HCV) Business (2018-2023) & (US$ Million)
    Table 55. Merck Recent Development
    Table 56. AbbVie Company Detail
    Table 57. AbbVie Business Overview
    Table 58. AbbVie Hepatitis C Virus (HCV) Product
    Table 59. AbbVie Revenue in Hepatitis C Virus (HCV) Business (2018-2023) & (US$ Million)
    Table 60. AbbVie Recent Development
    Table 61. J&J Company Detail
    Table 62. J&J Business Overview
    Table 63. J&J Hepatitis C Virus (HCV) Product
    Table 64. J&J Revenue in Hepatitis C Virus (HCV) Business (2018-2023) & (US$ Million)
    Table 65. J&J Recent Development
    Table 66. Bristol-Myers Squibb Company Detail
    Table 67. Bristol-Myers Squibb Business Overview
    Table 68. Bristol-Myers Squibb Hepatitis C Virus (HCV) Product
    Table 69. Bristol-Myers Squibb Revenue in Hepatitis C Virus (HCV) Business (2018-2023) & (US$ Million)
    Table 70. Bristol-Myers Squibb Recent Development
    Table 71. Kawin Company Detail
    Table 72. Kawin Business Overview
    Table 73. Kawin Hepatitis C Virus (HCV) Product
    Table 74. Kawin Revenue in Hepatitis C Virus (HCV) Business (2018-2023) & (US$ Million)
    Table 75. Kawin Recent Development
    Table 76. Abbott Company Detail
    Table 77. Abbott Business Overview
    Table 78. Abbott Hepatitis C Virus (HCV) Product
    Table 79. Abbott Revenue in Hepatitis C Virus (HCV) Business (2018-2023) & (US$ Million)
    Table 80. Abbott Recent Development
    Table 81. Siemens Healthineers Company Detail
    Table 82. Siemens Healthineers Business Overview
    Table 83. Siemens Healthineers Hepatitis C Virus (HCV) Product
    Table 84. Siemens Healthineers Revenue in Hepatitis C Virus (HCV) Business (2018-2023) & (US$ Million)
    Table 85. Siemens Healthineers Recent Development
    Table 86. Roche Diagnostics Company Detail
    Table 87. Roche Diagnostics Business Overview
    Table 88. Roche Diagnostics Hepatitis C Virus (HCV) Product
    Table 89. Roche Diagnostics Revenue in Hepatitis C Virus (HCV) Business (2018-2023) & (US$ Million)
    Table 90. Roche Diagnostics Recent Development
    Table 91. altona Diagnostics Company Detail
    Table 92. altona Diagnostics Business Overview
    Table 93. altona Diagnostics Hepatitis C Virus (HCV) Product
    Table 94. altona Diagnostics Revenue in Hepatitis C Virus (HCV) Business (2018-2023) & (US$ Million)
    Table 95. altona Diagnostics Recent Development
    Table 96. GeneProof Company Detail
    Table 97. GeneProof Business Overview
    Table 98. GeneProof Hepatitis C Virus (HCV) Product
    Table 99. GeneProof Revenue in Hepatitis C Virus (HCV) Business (2018-2023) & (US$ Million)
    Table 100. GeneProof Recent Development
    Table 101. Sansure Biotech Company Detail
    Table 102. Sansure Biotech Business Overview
    Table 103. Sansure Biotech Hepatitis C Virus (HCV) Product
    Table 104. Sansure Biotech Revenue in Hepatitis C Virus (HCV) Business (2018-2023) & (US$ Million)
    Table 105. Sansure Biotech Recent Development
    Table 106. Daan Gene Company Detail
    Table 107. Daan Gene Business Overview
    Table 108. Daan Gene Hepatitis C Virus (HCV) Product
    Table 109. Daan Gene Revenue in Hepatitis C Virus (HCV) Business (2018-2023) & (US$ Million)
    Table 110. Daan Gene Recent Development
    Table 111. BGI Group Company Detail
    Table 112. BGI Group Business Overview
    Table 113. BGI Group Hepatitis C Virus (HCV) Product
    Table 114. BGI Group Revenue in Hepatitis C Virus (HCV) Business (2018-2023) & (US$ Million)
    Table 115. BGI Group Recent Development
    Table 116. Abiores Company Detail
    Table 117. Abiores Business Overview
    Table 118. Abiores Hepatitis C Virus (HCV) Product
    Table 119. Abiores Revenue in Hepatitis C Virus (HCV) Business (2018-2023) & (US$ Million)
    Table 120. Abiores Recent Development
    Table 121. ACON Biotech Company Detail
    Table 122. ACON Biotech Business Overview
    Table 123. ACON Biotech Hepatitis C Virus (HCV) Product
    Table 124. ACON Biotech Revenue in Hepatitis C Virus (HCV) Business (2018-2023) & (US$ Million)
    Table 125. ACON Biotech Recent Development
    Table 126. Nectar Lifesciences Company Detail
    Table 127. Nectar Lifesciences Business Overview
    Table 128. Nectar Lifesciences Hepatitis C Virus (HCV) Product
    Table 129. Nectar Lifesciences Revenue in Hepatitis C Virus (HCV) Business (2018-2023) & (US$ Million)
    Table 130. Nectar Lifesciences Recent Development
    Table 131. Everlywell Company Detail
    Table 132. Everlywell Business Overview
    Table 133. Everlywell Hepatitis C Virus (HCV) Product
    Table 134. Everlywell Revenue in Hepatitis C Virus (HCV) Business (2018-2023) & (US$ Million)
    Table 135. Everlywell Recent Development
    Table 136. bioLytical Company Detail
    Table 137. bioLytical Business Overview
    Table 138. bioLytical Hepatitis C Virus (HCV) Product
    Table 139. bioLytical Revenue in Hepatitis C Virus (HCV) Business (2018-2023) & (US$ Million)
    Table 140. bioLytical Recent Development
    Table 141. Liferiver Company Detail
    Table 142. Liferiver Business Overview
    Table 143. Liferiver Hepatitis C Virus (HCV) Product
    Table 144. Liferiver Revenue in Hepatitis C Virus (HCV) Business (2018-2023) & (US$ Million)
    Table 145. Liferiver Recent Development
    Table 146. 3B BlackBio Biotech India Limited Company Detail
    Table 147. 3B BlackBio Biotech India Limited Business Overview
    Table 148. 3B BlackBio Biotech India Limited Hepatitis C Virus (HCV) Product
    Table 149. 3B BlackBio Biotech India Limited Revenue in Hepatitis C Virus (HCV) Business (2018-2023) & (US$ Million)
    Table 150. 3B BlackBio Biotech India Limited Recent Development
    Table 151. Research Programs/Design for This Report
    Table 152. Key Data Information from Secondary Sources
    Table 153. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Hepatitis C Virus (HCV) Market Size Comparison by Type (2023-2029) & (US$ Million)
    Figure 2. Global Hepatitis C Virus (HCV) Market Share by Type: 2022 VS 2029
    Figure 3. Hepatitis C Drugs Features
    Figure 4. Hepatitis C Test Kit Features
    Figure 5. Global Hepatitis C Virus (HCV) Market Size Comparison by Application (2023-2029) & (US$ Million)
    Figure 6. Global Hepatitis C Virus (HCV) Market Share by Application: 2022 VS 2029
    Figure 7. Hospitals Case Studies
    Figure 8. Ambulatory Surgical Centers Case Studies
    Figure 9. Diagnostic Centers Case Studies
    Figure 10. Hepatitis C Virus (HCV) Report Years Considered
    Figure 11. Global Hepatitis C Virus (HCV) Market Size (US$ Million), Year-over-Year: 2018-2029
    Figure 12. Global Hepatitis C Virus (HCV) Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 13. Global Hepatitis C Virus (HCV) Market Share by Region: 2022 VS 2029
    Figure 14. Global Hepatitis C Virus (HCV) Market Share by Players in 2022
    Figure 15. Global Top Hepatitis C Virus (HCV) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis C Virus (HCV) as of 2022)
    Figure 16. The Top 10 and 5 Players Market Share by Hepatitis C Virus (HCV) Revenue in 2022
    Figure 17. North America Hepatitis C Virus (HCV) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 18. North America Hepatitis C Virus (HCV) Market Share by Country (2018-2029)
    Figure 19. United States Hepatitis C Virus (HCV) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 20. Canada Hepatitis C Virus (HCV) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 21. Europe Hepatitis C Virus (HCV) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 22. Europe Hepatitis C Virus (HCV) Market Share by Country (2018-2029)
    Figure 23. Germany Hepatitis C Virus (HCV) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 24. France Hepatitis C Virus (HCV) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 25. U.K. Hepatitis C Virus (HCV) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 26. Italy Hepatitis C Virus (HCV) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 27. Russia Hepatitis C Virus (HCV) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 28. Nordic Countries Hepatitis C Virus (HCV) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 29. Asia-Pacific Hepatitis C Virus (HCV) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 30. Asia-Pacific Hepatitis C Virus (HCV) Market Share by Region (2018-2029)
    Figure 31. China Hepatitis C Virus (HCV) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 32. Japan Hepatitis C Virus (HCV) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 33. South Korea Hepatitis C Virus (HCV) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 34. Southeast Asia Hepatitis C Virus (HCV) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 35. India Hepatitis C Virus (HCV) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 36. Australia Hepatitis C Virus (HCV) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 37. Latin America Hepatitis C Virus (HCV) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 38. Latin America Hepatitis C Virus (HCV) Market Share by Country (2018-2029)
    Figure 39. Mexico Hepatitis C Virus (HCV) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 40. Brazil Hepatitis C Virus (HCV) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 41. Middle East & Africa Hepatitis C Virus (HCV) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 42. Middle East & Africa Hepatitis C Virus (HCV) Market Share by Country (2018-2029)
    Figure 43. Turkey Hepatitis C Virus (HCV) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 44. Saudi Arabia Hepatitis C Virus (HCV) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 45. Gilead Revenue Growth Rate in Hepatitis C Virus (HCV) Business (2018-2023)
    Figure 46. Merck Revenue Growth Rate in Hepatitis C Virus (HCV) Business (2018-2023)
    Figure 47. AbbVie Revenue Growth Rate in Hepatitis C Virus (HCV) Business (2018-2023)
    Figure 48. J&J Revenue Growth Rate in Hepatitis C Virus (HCV) Business (2018-2023)
    Figure 49. Bristol-Myers Squibb Revenue Growth Rate in Hepatitis C Virus (HCV) Business (2018-2023)
    Figure 50. Kawin Revenue Growth Rate in Hepatitis C Virus (HCV) Business (2018-2023)
    Figure 51. Abbott Revenue Growth Rate in Hepatitis C Virus (HCV) Business (2018-2023)
    Figure 52. Siemens Healthineers Revenue Growth Rate in Hepatitis C Virus (HCV) Business (2018-2023)
    Figure 53. Roche Diagnostics Revenue Growth Rate in Hepatitis C Virus (HCV) Business (2018-2023)
    Figure 54. altona Diagnostics Revenue Growth Rate in Hepatitis C Virus (HCV) Business (2018-2023)
    Figure 55. GeneProof Revenue Growth Rate in Hepatitis C Virus (HCV) Business (2018-2023)
    Figure 56. Sansure Biotech Revenue Growth Rate in Hepatitis C Virus (HCV) Business (2018-2023)
    Figure 57. Daan Gene Revenue Growth Rate in Hepatitis C Virus (HCV) Business (2018-2023)
    Figure 58. BGI Group Revenue Growth Rate in Hepatitis C Virus (HCV) Business (2018-2023)
    Figure 59. Abiores Revenue Growth Rate in Hepatitis C Virus (HCV) Business (2018-2023)
    Figure 60. ACON Biotech Revenue Growth Rate in Hepatitis C Virus (HCV) Business (2018-2023)
    Figure 61. Nectar Lifesciences Revenue Growth Rate in Hepatitis C Virus (HCV) Business (2018-2023)
    Figure 62. Everlywell Revenue Growth Rate in Hepatitis C Virus (HCV) Business (2018-2023)
    Figure 63. bioLytical Revenue Growth Rate in Hepatitis C Virus (HCV) Business (2018-2023)
    Figure 64. Liferiver Revenue Growth Rate in Hepatitis C Virus (HCV) Business (2018-2023)
    Figure 65. 3B BlackBio Biotech India Limited Revenue Growth Rate in Hepatitis C Virus (HCV) Business (2018-2023)
    Figure 66. Bottom-up and Top-down Approaches for This Report
    Figure 67. Data Triangulation
    Figure 68. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Gilead
Merck
AbbVie
J&J
Bristol-Myers Squibb
Kawin
Abbott
Siemens Healthineers
Roche Diagnostics
altona Diagnostics
GeneProof
Sansure Biotech
Daan Gene
BGI Group
Abiores
ACON Biotech
Nectar Lifesciences
Everlywell
bioLytical
Liferiver
3B BlackBio Biotech India Limited
Frequently Asked Questions
Hepatitis C Virus (HCV) report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Hepatitis C Virus (HCV) report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Hepatitis C Virus (HCV) report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Knee & Hip Disorders

This report aims to provide a comprehensive presentation of the global market for Knee & Hip Diso ... Read More

Lupus Nephritis

This report aims to provide a comprehensive presentation of the global market for Lupus Nephritis ... Read More